Compare KraneShares CSI China Internet ETF (KWEB) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KraneShares CSI China Internet ETF vs Medtronic PLC — how do they compare? KraneShares CSI China Internet ETF trades at $27.1, while Medtronic PLC trades at $82.73 (market cap $106.61B). The key difference: Medtronic PLC pays a 3.46% dividend while KraneShares CSI China Internet ETF pays none, and Medtronic PLC is trading nearer its 52-week high, KraneShares CSI China Internet ETF nearer its low. Which is the better fit depends on your goals.
| KWEB | MDT | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $42.94 | $105.35 |
52-Week Low | $23.63 | $73.75 |
Market Cap | — | $106.61B |
Enterprise Value | — | $125.36B |
Dividend Yield | — | 3.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
KWEB, the KraneShares CSI China Internet ETF, trades at $27.44, up 2.35% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF offers exposure to leading Chinese internet and AI companies, currently near 52-week lows. Recent news highlights China's AI investment plans and factory rebound driven by AI hardware exports, providing potential growth catalysts amid economic stabilization efforts.
The outlook for KWEB is cautiously optimistic, with attractive valuations relative to Western peers and strong AI-driven growth potential. Key risks include US-China tensions, regulatory changes, and economic volatility. Analyst sentiment is mixed, balancing long-term value against near-term geopolitical and market uncertainties.
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About KraneShares CSI China Internet ETF
KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
